BioCryst Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $406,555 | $159,395 | $163,353 | $145,534 |
Gross Profit | 397,033 | 156,873 | 160,555 | 140,966 |
EBITDA | 266,196 | 32,126 | 28,397 | 24,583 |
EBIT | 262,152 | 31,791 | 28,068 | 24,252 |
Net Income | 245,845 | 12,899 | 5,085 | 32 |
Net Change In Cash | 406,555 | 159,395 | 163,353 | 145,534 |
Free Cash Flow | 449,865 | 39,767 | 41,123 | -27,660 |
Cash | 89,736 | 84,078 | 88,033 | 105,481 |
Basic Shares | 219,263 | 219,885 | 219,886 | 215,261 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $874,837 | $450,712 | $331,412 | $270,827 |
Gross Profit | 855,762 | 438,227 | 326,751 | 264,233 |
EBITDA | 347,652 | 12,808 | -116,335 | -143,854 |
EBIT | 346,263 | 11,562 | -117,990 | -145,291 |
Net Income | 263,861 | -88,881 | -226,539 | -247,116 |
Net Change In Cash | 874,837 | 450,712 | 331,412 | 270,827 |
Free Cash Flow | 347,369 | -53,144 | -97,309 | -163,201 |
Cash | 89,736 | 104,923 | 110,643 | 304,767 |
Basic Shares | 218,581 | 206,696 | 192,198 | 185,908 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $0.16 |
2025-06-30 | $0.02 |
2025-03-31 | $0.0001 |
